Literature DB >> 17804634

Extracellular glutamate concentration in hippocampal slice.

Melissa A Herman1, Craig E Jahr.   

Abstract

Synaptic glutamate transients resulting from vesicular exocytosis are superimposed on a low baseline concentration of glutamate in the extracellular space. Reported values of baseline glutamate concentrations range up to 4 microM. If glutamate were present tonically at low micromolar concentrations, many receptors, especially the high-affinity NMDA receptors (NMDARs), would be activated or desensitized, altering neuronal excitability. Using NMDARs expressed by CA1 pyramidal cells in acute hippocampal slices to monitor extracellular glutamate, we find that its baseline concentration is much lower, near 25 nM. In addition, superfusion of low micromolar concentrations of glutamate had no effect on neurons, indicating that glutamate transport prevents access to receptors within the slice. However, equipotent concentrations of NMDA, a nontransported agonist, depolarized neurons dramatically. We suggest that ambient concentrations of glutamate in vivo are also in the nanomolar range and are too low to cause significant receptor activation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17804634      PMCID: PMC2670936          DOI: 10.1523/JNEUROSCI.3009-07.2007

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  38 in total

1.  Inducible expression of the GLT-1 glutamate transporter in a CHO cell line selected for low endogenous glutamate uptake.

Authors:  L M Levy; D Attwell; F Hoover; J F Ash; M Bjørås; N C Danbolt
Journal:  FEBS Lett       Date:  1998-02-06       Impact factor: 4.124

2.  Synaptic activation of glutamate transporters in hippocampal astrocytes.

Authors:  D E Bergles; C E Jahr
Journal:  Neuron       Date:  1997-12       Impact factor: 17.173

3.  Postsynaptic glutamate uptake in rat cerebellar Purkinje cells.

Authors:  M Takahashi; M Sarantis; D Attwell
Journal:  J Physiol       Date:  1996-12-01       Impact factor: 5.182

4.  Extrasynaptic glutamate spillover in the hippocampus: dependence on temperature and the role of active glutamate uptake.

Authors:  F Asztely; G Erdemli; D M Kullmann
Journal:  Neuron       Date:  1997-02       Impact factor: 17.173

Review 5.  Pharmacology and functions of metabotropic glutamate receptors.

Authors:  P J Conn; J P Pin
Journal:  Annu Rev Pharmacol Toxicol       Date:  1997       Impact factor: 13.820

6.  Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1.

Authors:  K Tanaka; K Watase; T Manabe; K Yamada; M Watanabe; K Takahashi; H Iwama; T Nishikawa; N Ichihara; T Kikuchi; S Okuyama; N Kawashima; S Hori; M Takimoto; K Wada
Journal:  Science       Date:  1997-06-13       Impact factor: 47.728

7.  Transporters buffer synaptically released glutamate on a submillisecond time scale.

Authors:  J S Diamond; C E Jahr
Journal:  J Neurosci       Date:  1997-06-15       Impact factor: 6.167

8.  Inhibition of uptake unmasks rapid extracellular turnover of glutamate of nonvesicular origin.

Authors:  D Jabaudon; K Shimamoto; Y Yasuda-Kamatani; M Scanziani; B H Gähwiler; U Gerber
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

9.  Glutamate release monitored with astrocyte transporter currents during LTP.

Authors:  J S Diamond; D E Bergles; C E Jahr
Journal:  Neuron       Date:  1998-08       Impact factor: 17.173

10.  The number of glutamate transporter subtype molecules at glutamatergic synapses: chemical and stereological quantification in young adult rat brain.

Authors:  K P Lehre; N C Danbolt
Journal:  J Neurosci       Date:  1998-11-01       Impact factor: 6.167

View more
  148 in total

1.  Aberrant detergent-insoluble excitatory amino acid transporter 2 accumulates in Alzheimer disease.

Authors:  Randall L Woltjer; Kevin Duerson; Joseph M Fullmer; Paramita Mookherjee; Allison M Ryan; Thomas J Montine; Jeffrey A Kaye; Joseph F Quinn; Lisa Silbert; Deniz Erten-Lyons; James B Leverenz; Thomas D Bird; David V Pow; Kohichi Tanaka; G Stennis Watson; David G Cook
Journal:  J Neuropathol Exp Neurol       Date:  2010-07       Impact factor: 3.685

Review 2.  New medications for drug addiction hiding in glutamatergic neuroplasticity.

Authors:  P W Kalivas; N D Volkow
Journal:  Mol Psychiatry       Date:  2011-04-26       Impact factor: 15.992

3.  Tonic NMDA receptor-mediated current in prefrontal cortical pyramidal cells and fast-spiking interneurons.

Authors:  Nadezhda V Povysheva; Jon W Johnson
Journal:  J Neurophysiol       Date:  2012-01-11       Impact factor: 2.714

Review 4.  Neurotransmitters and integration in neuronal-astroglial networks.

Authors:  Alexei Verkhratsky; José Julio Rodríguez; Vladimir Parpura
Journal:  Neurochem Res       Date:  2012-04-03       Impact factor: 3.996

Review 5.  Intercellular glutamate signaling in the nervous system and beyond.

Authors:  David E Featherstone
Journal:  ACS Chem Neurosci       Date:  2009-10-09       Impact factor: 4.418

6.  The glutamate transporter, GLAST, participates in a macromolecular complex that supports glutamate metabolism.

Authors:  Deborah E Bauer; Joshua G Jackson; Elizabeth N Genda; Misty M Montoya; Marc Yudkoff; Michael B Robinson
Journal:  Neurochem Int       Date:  2012-01-28       Impact factor: 3.921

7.  Synapse-specific expression of functional presynaptic NMDA receptors in rat somatosensory cortex.

Authors:  Daniel J Brasier; Daniel E Feldman
Journal:  J Neurosci       Date:  2008-02-27       Impact factor: 6.167

8.  An engineered glutamate-gated chloride (GluCl) channel for sensitive, consistent neuronal silencing by ivermectin.

Authors:  Shawnalea J Frazier; Bruce N Cohen; Henry A Lester
Journal:  J Biol Chem       Date:  2013-05-29       Impact factor: 5.157

Review 9.  Glutamate transporters in the biology of malignant gliomas.

Authors:  Stephanie M Robert; Harald Sontheimer
Journal:  Cell Mol Life Sci       Date:  2013-11-27       Impact factor: 9.261

10.  Decreased expression of GLT-1 in the R6/2 model of Huntington's disease does not worsen disease progression.

Authors:  Geraldine T Petr; Laurel A Schultheis; Kayla C Hussey; Yan Sun; Janet M Dubinsky; Chiye Aoki; Paul A Rosenberg
Journal:  Eur J Neurosci       Date:  2013-04-16       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.